|
|
|
|
|
|
Amicus Therapeutics (FOLD)
|
|
10.17 +0.23 (+2.31%)
|
6/22/2017 12:14pm
|
|
Open:
|
9.99
|
Pre. Close:
|
9.94
|
|
High:
|
10.24
|
Low:
|
9.82
|
|
Volume:
|
2,024,847
|
Market Cap:
|
1.45B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
10.12 - 10.29
|
10.29 - 10.43
|
|
Low:
|
9.02 - 9.22
|
9.22 - 9.38
|
|
Close:
|
9.61 - 9.93
|
9.93 - 10.2
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-21 4:32:08 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 11.91 One year: 13.92
|
|
Support:
|
Support1: 8.48 Support2: 7.41
|
|
Resistance:
|
Resistance1:
10.20 Resistance2: 11.91
|
|
Pivot:
|
8.74
|
|
Moving Averages:
|
MA(5): 9.52 MA(20): 8.62
MA(100): 7.24 MA(250): 6.87
|
|
MACD:
|
MACD(12,26):
0.53 Signal(12,26,9): 0.39
|
|
%K %D:
|
%K(14,3): 85.58  %D(3): 88.39
|
|
RSI:
|
RSI(14): 72.36
|
|
52-Week:
|
High: 10.24
Low: 4.41 Change(%): 72.6
|
|
Average Vol(K):
|
3-Month: 135127
10-Days 3035
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.FOLD has closed below upper band by 3.7%. Bollinger Bands are 96.9% wider than normal. The large width of the bands suggest high volatility as compared to FOLD's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Wed, 21 Jun 2017 11:37:30 GMT
Amicus Therapeutics: Elucidating The Bullish And Bearish Claims
Wed, 24 May 2017 19:41:15 GMT
Amicus Therapeutics: A Rare Find In Biotechnology
Mon, 19 Jun 2017 13:18:45 GMT
Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 7.3%
Fri, 16 Jun 2017 11:26:15 GMT
New Data Validate Amicus's Pompe Disease Candidate
Wed, 21 Jun 2017 21:30:06 GMT
Amicus Therapeutics Inc. (FOLD) Moves Higher on Volume Spike for June 21
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
